Axsome Therapeutics (AXSM) Raw Materials (2022 - 2026)
Axsome Therapeutics' Raw Materials was $11.4 million in Q3 2026, down 8.3% from $12.44 million a year earlier and down 8.7% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Raw Materials (2022 - 2026) Analysis & Trends
At the end of FY2025, Raw Materials at Axsome Therapeutics came in at $10.38 million, up 8.8% from FY2024.
- Raw Materials has now increased for three consecutive years, with a three-year compound annual growth rate of 61.3% (FY2022 to FY2025).
- In earlier years, Raw Materials was $9.54 million in FY2024 (+72.4%), $5.53 million in FY2023 (+123.8%) and $2.47 million in FY2022.
- Quarterly Raw Materials has moved between $2.15 million (Q3 2022) and $12.49 million (Q2 2026) over five years.
- Compared with a year earlier, Raw Materials was higher in seven of the last eight quarters, with growth averaging 37.5%.
- The best year-over-year quarter for Raw Materials over five years was Q4 2023 (growth of 123.8%); the worst was Q3 2026 (a decline of 8.3%).
- Per Business Quant data, AXSM's Raw Materials in the three quarters before Q3 2026 was $12.49 million (Q2 2026), $11.86 million (Q1 2026) and $10.38 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Axsome Therapeutics | 7.37 Bn | 6.11 Bn | 241.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.40 Mn |
| Jun 30, 2026 | 12.49 Mn |
| Mar 31, 2026 | 11.86 Mn |
| Dec 31, 2025 | 10.38 Mn |
| Sep 30, 2025 | 12.44 Mn |
| Jun 30, 2025 | 11.72 Mn |
| Mar 31, 2025 | 11.53 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Sep 30, 2024 | 7.75 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 5.58 Mn |
| Dec 31, 2023 | 5.53 Mn |
| Sep 30, 2023 | 4.51 Mn |
| Jun 30, 2023 | 4.01 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 2.47 Mn |
| Sep 30, 2022 | 2.15 Mn |
API Access
Axsome Therapeutics Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();